Clinical trial NCT02272010 - References

Bipolar Disorder — Dietary Intervention for Bipolar Disorder

Citation(s)

•   aan het Rot M, Hogenelst K, Schoevers RA
  Mood disorders in everyday life: a systematic review of experience sampling and ecological momentary assessment studies. Clin Psychol Rev. 2012 Aug;32(6):510-23. doi: 10.1016/j.cpr.2012.05.007. Epub 2012 Jun 6. Review.
•   Altman EG, Hedeker DR, Janicak PG, Peterson JL, Davis JM
  The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability, and validity. Biol Psychiatry. 1994 Jul 15;36(2):124-34.
•   Antonova M, Wienecke T, Olesen J, Ashina M
  Prostaglandin E(2) induces immediate migraine-like attack in migraine patients without aura. Cephalalgia. 2012 Aug;32(11):822-33. doi: 10.1177/0333102412451360. Epub 2012 Jun 19.
•   BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E
  Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 2010 Jan 30;375(9712):385-95. doi: 10.1016/S0140-6736(09)61828-6. Epub 2010 Jan 19.
•   Basselin M, Kim HW, Chen M, Ma K, Rapoport SI, Murphy RC, Farias SE
  Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation. J Lipid Res. 2010 May;51(5):1049-56. doi: 10.1194/jlr.M002469. Epub 2009 Dec 29. Retraction in: J Lipid Res. 2018 Aug;59(8):1547.
•   Bauer J, Gottfries GG, Förstl H
  Critical comments on "Propionibacterium acnes in the cortex of patients with Alzheimer's disease" by H.H. Kornhuber (Eur Arch Psychiatry Clin Neurosci, 1996, 246:108-109). Eur Arch Psychiatry Clin Neurosci. 1996;246(4):224-6.
•   Bauer M, Glenn T, Alda M, Grof P, Sagduyu K, Bauer R, Lewitzka U, Whybrow PC
  Comparison of pre-episode and pre-remission states using mood ratings from patients with bipolar disorder. Pharmacopsychiatry. 2011 May;44 Suppl 1:S49-53. doi: 10.1055/s-0031-1273765. Epub 2011 May 4.
•   Bauer M, Glenn T, Grof P, Pfennig A, Rasgon NL, Marsh W, Munoz RA, Sagduyu K, Alda M, Quiroz D, Sasse J, Whybrow PC
  Self-reported data from patients with bipolar disorder: frequency of brief depression. J Affect Disord. 2007 Aug;101(1-3):227-33. Epub 2007 Jan 16.
•   Bauer M, Glenn T, Grof P, Schmid R, Pfennig A, Whybrow PC
  Subsyndromal mood symptoms: a useful concept for maintenance studies of bipolar disorder? Psychopathology. 2010;43(1):1-7. doi: 10.1159/000255957. Epub 2009 Nov 6. Review.
•   Bauer M, Glenn T, Keil M, Bauer R, Marsh W, Grof P, Alda M, Sagduyu K, Murray G, Quiroz D, Baethge C, Whybrow PC
  Brief depressive symptoms in patients with bipolar disorder: analysis of long-term self-reported data. Aust N Z J Psychiatry. 2012 Nov;46(11):1068-78. doi: 10.1177/0004867412452017. Epub 2012 Jun 25.
•   Bauer M, Glenn T, Whybrow PC, Grof P, Rasgon N, Alda M, Marsh W, Sagduyu K, Schmid R, Adli M
  Changes in self-reported sleep duration predict mood changes in bipolar disorder. Psychol Med. 2008 Jul;38(7):1069-71. doi: 10.1017/S0033291708003280. Epub 2008 Apr 1.
•   Bauer M, Wilson T, Neuhaus K, Sasse J, Pfennig A, Lewitzka U, Grof P, Glenn T, Rasgon N, Bschor T, Whybrow PC
  Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania. Psychiatry Res. 2008 Jun 30;159(3):359-66. doi: 10.1016/j.psychres.2007.04.013. Epub 2008 Apr 18.
•   Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS
  Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev. 2011 Jan;35(3):804-17. doi: 10.1016/j.neubiorev.2010.10.001. Epub 2010 Oct 8. Review.
•   Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ
  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.
•   Cheon Y, Park JY, Modi HR, Kim HW, Lee HJ, Chang L, Rao JS, Rapoport SI
  Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E2 concentration in rat brain. J Neurochem. 2011 Oct;119(2):364-76. doi: 10.1111/j.1471-4159.2011.07410.x. Epub 2011 Sep 20.
•   Chiu CC, Huang SY, Su KP, Lu ML, Huang MC, Chen CC, Shen WW
  Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol. 2003 Mar;13(2):99-103.
•   Davidson J, Turnbull CD, Strickland R, Miller R, Graves K
  The Montgomery-Asberg Depression Scale: reliability and validity. Acta Psychiatr Scand. 1986 May;73(5):544-8.
•   Devilly GJ, Borkovec TD
  Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86.
•   Evans SJ, Kamali M, Prossin AR, Harrington GJ, Ellingrod VL, McInnis MG, Burant CF
  Association of plasma ?-3 and ?-6 lipids with burden of disease measures in bipolar subjects. J Psychiatr Res. 2012 Nov;46(11):1435-41. doi: 10.1016/j.jpsychires.2012.07.016. Epub 2012 Aug 11.
•   Evans SJ, Prossin AR, Harrington GJ, Kamali M, Ellingrod VL, Burant CF, McInnis MG
  Fats and factors: lipid profiles associate with personality factors and suicidal history in bipolar subjects. PLoS One. 2012;7(1):e29297. doi: 10.1371/journal.pone.0029297. Epub 2012 Jan 13.
•   Frangou S, Lewis M, McCrone P
  Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006 Jan;188:46-50.
•   Frangou S, Lewis M, Wollard J, Simmons A
  Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. J Psychopharmacol. 2007 Jun;21(4):435-9. Epub 2006 Aug 4.
•   Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE Jr, Marangell LB, Richardson AJ, Lake J, Stoll AL
  Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006 Dec;67(12):1954-67. Review. Erratum in: J Clin Psychiatry. 2007 Feb;68(2):338.
•   Gray MJ, Litz BT, Hsu JL, Lombardo TW
  Psychometric properties of the life events checklist. Assessment. 2004 Dec;11(4):330-41.
•   Hamer RM, Simpson PM
  Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials. Am J Psychiatry. 2009 Jun;166(6):639-41. doi: 10.1176/appi.ajp.2009.09040458.
•   Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE
  Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006 Jun;83(6 Suppl):1483S-1493S. doi: 10.1093/ajcn/83.6.1483S.
•   Hibbeln JR, Palmer JW, Davis JM
  Are disturbances in lipid-protein interactions by phospholipase-A2 a predisposing factor in affective illness? Biol Psychiatry. 1989 Apr 1;25(7):945-61. Review.
•   Horne JA, Ostberg O
  A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2):97-110.
•   Jen A, Saunders EF, Ornstein RM, Kamali M, McInnis MG
  Impulsivity, anxiety, and alcohol misuse in bipolar disorder comorbid with eating disorders. Int J Bipolar Disord. 2013 Aug 6;1:13. doi: 10.1186/2194-7511-1-13. eCollection 2013.
•   Johns MW
  A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5.
•   Judd LL, Akiskal HS, Schettler PJ, Endicott J, Leon AC, Solomon DA, Coryell W, Maser JD, Keller MB
  Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry. 2005 Dec;62(12):1322-30.
•   Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB
  The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002 Jun;59(6):530-7.
•   Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM
  Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry. 2006 Nov 1;60(9):1020-2. Epub 2006 Jun 30.
•   Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC
  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987 Jun;44(6):540-8.
•   Kim HW, Cheon Y, Modi HR, Rapoport SI, Rao JS
  Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain. Psychopharmacology (Berl). 2012 Aug;222(4):663-74. doi: 10.1007/s00213-012-2671-7. Epub 2012 Mar 14.
•   Kim HW, Rapoport SI, Rao JS
  Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol Psychiatry. 2011 Apr;16(4):419-28. doi: 10.1038/mp.2009.137. Epub 2009 Dec 29.
•   Kim HW, Rapoport SI, Rao JS
  Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis. 2010 Mar;37(3):596-603. doi: 10.1016/j.nbd.2009.11.010. Epub 2009 Nov 26.
•   Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, Cady R, Dahlöf CG, Dowson A, Tepper S
  A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003 Dec;12(8):963-74.
•   Kraguljac NV, Montori VM, Pavuluri M, Chai HS, Wilson BS, Unal SS
  Efficacy of omega-3 fatty acids in mood disorders - a systematic review and metaanalysis. Psychopharmacol Bull. 2009;42(3):39-54. Review.
•   Lee HJ, Ertley RN, Rapoport SI, Bazinet RP, Rao JS
  Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex. Neurochem Res. 2008 May;33(5):861-6. Epub 2007 Dec 14.
•   Lee HJ, Rao JS, Chang L, Rapoport SI, Kim HW
  Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder? Mol Psychiatry. 2010 Jun;15(6):602-14. doi: 10.1038/mp.2008.117. Epub 2008 Nov 4.
•   Linde M, Mulleners WM, Chronicle EP, McCrory DC
  Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013 Jun 24;(6):CD010611. doi: 10.1002/14651858.CD010611. Review.
•   McKee SA AM, Kochetkova A, Maciejewski P, O'Malley S, Krishnan-Sarin S, & Mazure CM
  A new measure for assessing the impact of stressful events on smoking behavior. Annual Meeting of the Society for Research on Nicotine and Tobacco; Prague, CZ2005. p. 16.
•   McNamara RK, Jandacek R, Rider T, Tso P, Dwivedi Y, Pandey GN
  Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord. 2010 Oct;126(1-2):303-11. doi: 10.1016/j.jad.2010.03.015. Epub 2010 Apr 21.
•   Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC
  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007 May;64(5):543-52. Erratum in: Arch Gen Psychiatry. 2007 Sep;64(9):1039.
•   Modi HR, Taha AY, Kim HW, Chang L, Rapoport SI, Cheon Y
  Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability. J Neurochem. 2013 Feb;124(3):376-87. doi: 10.1111/jnc.12078. Epub 2012 Dec 6. Erratum in: J Neurochem. 2013 May;125(3):486.
•   Montgomery SA, Asberg M
  A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979 Apr;134:382-9.
•   Murphy BL, Stoll AL, Harris PQ, Ravichandran C, Babb SM, Carlezon WA Jr, Cohen BM
  Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial. J Clin Psychopharmacol. 2012 Oct;32(5):699-703. doi: 10.1097/JCP.0b013e318266854c.
•   Myin-Germeys I, Oorschot M, Collip D, Lataster J, Delespaul P, van Os J
  Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med. 2009 Sep;39(9):1533-47. doi: 10.1017/S0033291708004947. Epub 2009 Feb 12. Review.
•   Myin-Germeys I, Peeters F, Havermans R, Nicolson NA, DeVries MW, Delespaul P, Van Os J
  Emotional reactivity to daily life stress in psychosis and affective disorder: an experience sampling study. Acta Psychiatr Scand. 2003 Feb;107(2):124-31.
•   Noaghiul S, Hibbeln JR
  Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am J Psychiatry. 2003 Dec;160(12):2222-7.
•   Ramsden CE, Faurot KR, Zamora D, Suchindran CM, Macintosh BA, Gaylord S, Ringel A, Hibbeln JR, Feldstein AE, Mori TA, Barden A, Lynch C, Coble R, Mas E, Palsson O, Barrow DA, Mann JD
  Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain. 2013 Nov;154(11):2441-51. doi: 10.1016/j.pain.2013.07.028. Epub 2013 Jul 22.
•   Rao JS, Harry GJ, Rapoport SI, Kim HW
  Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry. 2010 Apr;15(4):384-92. doi: 10.1038/mp.2009.47. Epub 2009 Jun 2.
•   Rao JS, Keleshian VL, Klein S, Rapoport SI
  Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Transl Psychiatry. 2012 Jul 3;2:e132. doi: 10.1038/tp.2012.55.
•   Rao JS, Kim HW, Kellom M, Greenstein D, Chen M, Kraft AD, Harry GJ, Rapoport SI, Basselin M
  Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats. J Neuroinflammation. 2011 Aug 16;8:101. doi: 10.1186/1742-2094-8-101. Erratum in: J Neuroinflammation. 2012;9:19. Retraction in: J Neuroinflammation. 2017 May 9;14 (1):95.
•   Rao JS, Rapoport SI
  Mood-stabilizers target the brain arachidonic acid cascade. Curr Mol Pharmacol. 2009 Jun;2(2):207-14. Review.
•   Rapoport SI, Basselin M, Kim HW, Rao JS
  Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res Rev. 2009 Oct;61(2):185-209. doi: 10.1016/j.brainresrev.2009.06.003. Epub 2009 Jun 23. Review.
•   Rapoport SI
  Arachidonic acid and the brain. J Nutr. 2008 Dec;138(12):2515-20.
•   Reese EA, Cheon Y, Ramadan E, Kim HW, Chang L, Rao JS, Rapoport SI, Taha AY
  Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder. Prostaglandins Leukot Essent Fatty Acids. 2012 Aug-Sep;87(2-3):71-7. doi: 10.1016/j.plefa.2012.06.003. Epub 2012 Jul 27.
•   Ruissen AM, Widdershoven GA, Meynen G, Abma TA, van Balkom AJ
  A systematic review of the literature about competence and poor insight. Acta Psychiatr Scand. 2012 Feb;125(2):103-13. doi: 10.1111/j.1600-0447.2011.01760.x. Epub 2011 Sep 8. Review.
•   Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M
  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993 Jun;88(6):791-804.
•   Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC
  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57. Review.
•   Shimshoni JA, Basselin M, Li LO, Coleman RA, Rapoport SI, Modi HR
  Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder. Biochim Biophys Acta. 2011 Mar;1811(3):163-9. doi: 10.1016/j.bbalip.2010.12.006. Epub 2010 Dec 22.
•   Siddiqui O, Hung HM, O'Neill R
  MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. J Biopharm Stat. 2009;19(2):227-46. doi: 10.1080/10543400802609797.
•   Snaith RP, Harrop FM, Newby DA, Teale C
  Grade scores of the Montgomery-Asberg Depression and the Clinical Anxiety Scales. Br J Psychiatry. 1986 May;148:599-601.
•   Soares JK, Rocha-de-Melo AP, Medeiros MC, Queiroga RC, Bomfim MA, de Souza AF, Nascimento AL, Guedes RC
  Conjugated linoleic acid in the maternal diet differentially enhances growth and cortical spreading depression in the rat progeny. Biochim Biophys Acta. 2012 Oct;1820(10):1490-5. doi: 10.1016/j.bbagen.2012.05.010. Epub 2012 Jun 1.
•   Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN
  Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000 Oct;88(1):41-52.
•   Stewart WF, Lipton RB, Whyte J, Dowson A, Kolodner K, Liberman JN, Sawyer J
  An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999 Sep 22;53(5):988-94.
•   Stoll AL, Locke CA, Marangell LB, Severus WE
  Omega-3 fatty acids and bipolar disorder: a review. Prostaglandins Leukot Essent Fatty Acids. 1999 May-Jun;60(5-6):329-37. Review.
•   Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB
  Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999 May;56(5):407-12.
•   Sublette ME, Bosetti F, DeMar JC, Ma K, Bell JM, Fagin-Jones S, Russ MJ, Rapoport SI
  Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disord. 2007 Nov;9(7):759-65.
•   Vieta E
  Guide to Assessment Scales in Bipolar Disorder. 2 ed. London, UK: Current Medicine Group Ltd; 2010.
•   Vinokur AD, van Ryn M
  Social support and undermining in close relationships: their independent effects on the mental health of unemployed persons. J Pers Soc Psychol. 1993 Aug;65(2):350-9.
•   Who
  The World Health Report: 2001: Mental health: new understanding, new hope. Geneva: World Health Organization; 2001.
•   Young RC, Biggs JT, Ziegler VE, Meyer DA
  A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978 Nov;133:429-35.

Targeted Alterations in n-3 and n‐6 Fatty Acids for the Management of Mood Variability in the Maintenance Phase of Bipolar Disorder

Details for clinical trial NCT02272010